Cite
Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
MLA
Barbieri, John S., et al. “Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.” Journal of Drugs in Dermatology : JDD, vol. 17, no. 6, June 2018, pp. 632–38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29879250&authtype=sso&custid=ns315887.
APA
Barbieri, J. S., Choi, J. K., Mitra, N., & Margolis, D. J. (2018). Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016. Journal of Drugs in Dermatology : JDD, 17(6), 632–638.
Chicago
Barbieri, John S, Juliana K Choi, Nandita Mitra, and David J Margolis. 2018. “Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.” Journal of Drugs in Dermatology : JDD 17 (6): 632–38. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29879250&authtype=sso&custid=ns315887.